ARCHIVES

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

DRCCA Board Okays Four Concepts, Rejects One, Tables Two Others

May 27, 1983

Cancer Control Seeks Grant Applications In Three Interventions Areas And In Community Development

September 13, 1974

Congressional Committees Add Provisions To Cancer Act Renewal Bills To Strengthen NCI’s Independence, Prevent Fund Withholding

March 8, 1974

Cost Of Cancer:$40 Billion In 1980, Now Probably Between $50-80 Billion; “The Tip Of The Iceberg”

February 25, 1983

NCI RFA: Basic Biobehavioral Research

August 6, 1999

Cullen Credits Staff With Success Of STCP, Strong Prevention Program a NCI

May 19, 1989